Ascend Wellness Q2 Revenue Rises 7.9% to $126.1M, Loss Narrows to $9.8M

summarizeSummary

Ascend Wellness reported Q2 2026 revenue of $126.1 million, up 7.9% sequentially, with Adjusted EBITDA of $29.1 million and a narrowed net loss of $9.8 million. The company generated positive free cash flow and expanded its retail footprint to 55 locations.

check_boxKey Events · Earnings and Guidance · AAWH

• Q2 Revenue Up 7.9% Sequentially

  Net revenue reached $126.1 million, up from $116.9 million in Q1 2026, driven by an 11.5% increase in retail revenue to $92.7 million.

• Adjusted EBITDA Rises to $29.1M

  Adjusted EBITDA increased 10.6% sequentially to $29.1 million, with margin expanding 60 basis points to 23.1%.

• Net Loss Narrows to $9.8M

  Net loss improved from $29.5 million in Q1 2026 to $9.8 million in Q2, helped by a $5.7 million income tax benefit.

• Positive Free Cash Flow of $19.5M

  Operating cash flow was $22.5 million, less $3.0 million in capital expenditures, yielding $19.5 million in free cash flow and boosting cash to $67.0 million.

auto_awesomeAnalysis · AAWH · Life Sciences

A strong sequential rebound marked Ascend Wellness's Q2 2026, with revenue climbing 7.9% to $126.1 million and Adjusted EBITDA up 10.6% to $29.1 million. The net loss narrowed sharply to $9.8 million from $29.5 million in Q1, while free cash flow of $19.5 million boosted cash to $67 million. Operational momentum is evident in the retail expansion to 55 locations and a 5% market share gain in a contracting environment. However, the company still carries $251.8 million in net debt and faces a potential Q3 impact from the resolved Barry facility work stoppage. The upcoming August 28 shareholder vote on a reverse stock split to enable uplisting adds a catalyst for the stock.